Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), today announced the first patient has been randomized and dosed in a Phase 2 clinical study evaluating sunobinop ...

Frequent urination often signals underlying health conditions that require medical attention. While occasional increases in ...

There is a wide range of variability with how often one should pee, particularly in regard to what’s “normal.” Learn if you ...

Key Takeaways Men’s incontinence is a common issue affecting many individuals globally. Understanding the types and causes ...

A young woman with breast cancer was experiencing such intense hot flashes from her triplet chemotherapy regimen, AC-T, that ...